AR044953A1 - Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico - Google Patents

Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico

Info

Publication number
AR044953A1
AR044953A1 ARP040102287A ARP040102287A AR044953A1 AR 044953 A1 AR044953 A1 AR 044953A1 AR P040102287 A ARP040102287 A AR P040102287A AR P040102287 A ARP040102287 A AR P040102287A AR 044953 A1 AR044953 A1 AR 044953A1
Authority
AR
Argentina
Prior art keywords
lactic acid
batteries
produce equol
daidzein
equol
Prior art date
Application number
ARP040102287A
Other languages
English (en)
Inventor
Shigeto Uchiyama
Tomomi Ueno
Toshimi Suzuki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR044953A1 publication Critical patent/AR044953A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Abstract

Se provee una composición que contiene bacterias de ácido láctico que producen equol que es efectiva para la prevención y el alivio de malestares, inclusive los trastornos climatéricos en mujeres de mediana edad y mayores, para las cuales no se encuentran disponibles hasta el momento métodos profilácticos o medios de alivio efectivos. Esta composición que contiene bacterias de ácido láctico que producen equol comprende, como un componente esencial de la misma, bacterias de ácido láctico del género Lactococus que tienen la capacidad de utilizar por lo menos un compuesto de daidzeína seleccionado entre el grupo que consiste en glicósido de daidzeína, daidzeína y dihidrodaidzeína para elaborar equol. Reivindicación 5: La composición de acuerdo con la reivindicación 4, caracterizada porque el ingrediente que contiene el compuesto de daidzeína es harina de porotos de soja o leche de soja.
ARP040102287A 2003-06-30 2004-06-30 Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico AR044953A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003187831 2003-06-30

Publications (1)

Publication Number Publication Date
AR044953A1 true AR044953A1 (es) 2005-10-12

Family

ID=33549734

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102287A AR044953A1 (es) 2003-06-30 2004-06-30 Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico

Country Status (22)

Country Link
US (3) US8765445B2 (es)
EP (2) EP1649760B1 (es)
JP (1) JP3864317B2 (es)
KR (2) KR101054631B1 (es)
CN (1) CN1826059B (es)
AR (1) AR044953A1 (es)
AU (1) AU2004251563B2 (es)
BR (1) BRPI0412180B1 (es)
CA (1) CA2531173C (es)
CY (2) CY1114248T1 (es)
DK (2) DK1649760T3 (es)
ES (2) ES2601885T3 (es)
HK (1) HK1090812A1 (es)
HU (1) HUE030615T2 (es)
MX (1) MXPA06000074A (es)
MY (1) MY146563A (es)
PL (2) PL2548455T3 (es)
PT (2) PT2548455T (es)
SG (1) SG157232A1 (es)
SI (2) SI1649760T1 (es)
TW (2) TW201118175A (es)
WO (1) WO2005000042A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2548455T (pt) * 2003-06-30 2016-11-09 Otsuka Pharma Co Ltd Composição contendo uma bactéria de ácido láctico produzindo equol
JP4811760B2 (ja) * 2004-12-27 2011-11-09 独立行政法人農業・食品産業技術総合研究機構 ダイゼイン資化によるエコール生成能を改善するための腸内細菌およびその利用
CA2628803C (en) * 2005-11-02 2016-07-05 Kabushiki Kaisha Yakult Honsha Equol level regulator
JP5030790B2 (ja) * 2005-12-06 2012-09-19 大塚製薬株式会社 エクオール含有大豆胚軸発酵物、及びその製造方法
JP2007308428A (ja) * 2006-05-19 2007-11-29 Fancl Corp 摂食抑制剤
JP5122766B2 (ja) * 2006-06-20 2013-01-16 ユニチカ株式会社 エコール産生促進組成物
WO2008146835A1 (ja) * 2007-05-28 2008-12-04 Fuji Oil Company, Limited エクオール非産生者用の血中エクオール産生促進組成物
AU2013203101B2 (en) * 2007-06-13 2015-07-09 Otsuka Pharmaceutical Co., Ltd. Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
MX2009013580A (es) 2007-06-13 2010-01-20 Otsuka Pharma Co Ltd Extracto que contiene equol, metodo para la produccion del mismo, metodo para la extraccion de equol, y alimento que contiene equol.
EP2209384B1 (en) * 2007-11-23 2011-08-10 Unilever N.V. Fermented soy-based beverage
PT2228441E (pt) * 2007-12-27 2013-08-27 Otsuka Pharma Co Ltd Enzima envolvida na síntese de equol
JP2009232712A (ja) * 2008-03-26 2009-10-15 Glico Dairy Products Co Ltd エクオール産生組成物，エクオール産生方法及びエクオール含有組成物
KR101600867B1 (ko) * 2008-06-03 2016-03-10 삼성전자주식회사 냉장고
AU2014240200B2 (en) * 2008-09-19 2015-08-13 Otsuka Pharmaceutical Co., Ltd. Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same
SG10201701701RA (en) * 2008-09-19 2017-04-27 Otsuka Pharma Co Ltd Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same
CA2753103C (en) * 2009-02-25 2017-09-12 Kabushiki Kaisha Yakult Honsha Equol-producing bacterium and use thereof
JP2011036190A (ja) * 2009-08-12 2011-02-24 Enseki Aojiru Kk 顆粒状経口食品の製造方法及びその顆粒状経口食品
JP5777287B2 (ja) * 2009-09-18 2015-09-09 大塚製薬株式会社 エクオール産生能が維持されたエクオール産生微生物を含む発酵製品、及びその製造方法
KR101024297B1 (ko) * 2010-08-11 2011-03-29 유익종 유산 발효에 의해 계란단백질의 항원성이 저하된 유산발효계란 및 그의 제조방법
CN102021130A (zh) * 2010-10-21 2011-04-20 南京农业大学 一株降解大豆苷原产生雌马酚的双酶梭菌及其菌剂和应用
US20120251511A1 (en) * 2011-03-28 2012-10-04 Eric Donald Murphy Composition and products for enabling the production of equol in vivo
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
ITMI20111829A1 (it) * 2011-10-07 2013-04-08 Paladin Pharma S P A Procedimento per la preparazione di una composizione a base di equolo
KR101307947B1 (ko) 2011-11-30 2013-09-12 씨제이제일제당 (주) 싸이코스를 유효성분으로 하는 에쿠올 농도 상승제
JP5996187B2 (ja) * 2011-12-20 2016-09-21 株式会社ダイセル エクオールの製造方法
WO2013146319A1 (ja) * 2012-03-30 2013-10-03 味の素株式会社 糖尿病誘起細菌
CN104087532B (zh) * 2014-07-04 2016-04-20 浙江省农业科学院 一种来源于鸡肠道的雌马酚产生梭菌c1-6及应用
KR102064055B1 (ko) 2018-02-08 2020-01-08 신선옥 에쿠올이 생성된 발효커피생두, 그 제조방법 및 그 추출물
JP2018186823A (ja) * 2018-07-13 2018-11-29 株式会社ダイセル イソフラバノン類の製造方法
WO2020210194A1 (en) * 2019-04-08 2020-10-15 Corn Products Development, Inc. Improved plant-protein based analog dairy compositions
US20220202757A1 (en) * 2019-04-09 2022-06-30 Martin Munzer Protein substitute amino acid compositions and products, and other food and beverage products
US11730778B2 (en) * 2019-09-24 2023-08-22 Access Business Group International Llc Method of increasing the level and production of metabolized phytonutrients in a subject
JPWO2021235278A1 (es) * 2020-05-21 2021-11-25
CN114150030A (zh) * 2021-12-24 2022-03-08 内蒙古金达威药业有限公司 一种透明质酸的生产方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322140C (zh) 1997-08-08 2007-06-20 大塚制药株式会社 含异黄酮的组合物
WO2004039327A2 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
AU2003259220C1 (en) * 2002-07-24 2017-08-24 Australian Health & Nutrition Association Limited Compositions and products containing enantiomeric equol, and methods for their making
JP2003081855A (ja) * 2002-08-19 2003-03-19 Yakult Honsha Co Ltd 脂質代謝改善剤およびそれを含有する食品
PT2548455T (pt) * 2003-06-30 2016-11-09 Otsuka Pharma Co Ltd Composição contendo uma bactéria de ácido láctico produzindo equol

Also Published As

Publication number Publication date
KR20060028436A (ko) 2006-03-29
CA2531173C (en) 2013-09-10
EP1649760A1 (en) 2006-04-26
PL2548455T3 (pl) 2017-03-31
SI1649760T1 (sl) 2013-07-31
KR20110044810A (ko) 2011-04-29
PT2548455T (pt) 2016-11-09
JPWO2005000042A1 (ja) 2006-07-27
CY1114248T1 (el) 2016-08-31
DK2548455T3 (en) 2016-11-28
US20140050703A1 (en) 2014-02-20
DK1649760T3 (da) 2013-07-08
WO2005000042A1 (ja) 2005-01-06
BRPI0412180A (pt) 2006-08-22
MY146563A (en) 2012-08-30
ES2601885T3 (es) 2017-02-16
ES2417481T3 (es) 2013-08-08
TWI335353B (en) 2011-01-01
KR101043465B1 (ko) 2011-06-23
CN1826059A (zh) 2006-08-30
AU2004251563B2 (en) 2009-04-23
CA2531173A1 (en) 2005-01-06
US20190038684A1 (en) 2019-02-07
EP1649760B1 (en) 2013-05-22
JP3864317B2 (ja) 2006-12-27
SG157232A1 (en) 2009-12-29
TW201118175A (en) 2011-06-01
CY1118534T1 (el) 2017-07-12
US8765445B2 (en) 2014-07-01
US10098915B2 (en) 2018-10-16
US20060148045A1 (en) 2006-07-06
EP2548455B1 (en) 2016-08-31
MXPA06000074A (es) 2006-03-21
AU2004251563A1 (en) 2005-01-06
KR101054631B1 (ko) 2011-08-04
PL1649760T3 (pl) 2013-10-31
HK1090812A1 (en) 2007-01-05
EP1649760A4 (en) 2008-06-25
SI2548455T1 (sl) 2016-11-30
EP2548455A1 (en) 2013-01-23
BRPI0412180B1 (pt) 2014-06-17
TW200510542A (en) 2005-03-16
PT1649760E (pt) 2013-06-25
HUE030615T2 (en) 2017-05-29
CN1826059B (zh) 2011-09-28

Similar Documents

Publication Publication Date Title
AR044953A1 (es) Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico
Braun et al. Quercetin protects primary human osteoblasts exposed to cigarette smoke through activation of the antioxidative enzymes HO-1 and SOD-1
CN104042528B (zh) 草本养发防脱去屑洗发原液及制作方法
JP2013523102A5 (es)
EE200400032A (et) Polüfenooliühendit sisaldav farmatseutiline toitekompositsioon ning selle kasutamine vähktõve ravimiseks
EA200701190A1 (ru) Композиция на основе растительных экстрактов ajuga reptans для предупреждения выпадения волос, стимулирования роста волос, регуляции продукции кожного сала
BRPI0511322A (pt) composições adequadas para o tratamento de sinais cutáneos provenientes do envelhecimento, tablete e formulação de tablete
EP1915997A4 (en) HAIR GROWTH FUNDS
EA200870526A1 (ru) Композиция, включающая по меньшей мере один высший алифатический спирт и экстракт griffonia simplicifolia
HK1098960A1 (en) Method and composition for treating rhinitis
WO2007077203A3 (en) Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
CA2503363A1 (en) Antioxidative compositions
ATE235885T1 (de) Antioxidative hautpflegemittel
WO2001089520A3 (en) Dehydroascorbic acid formulations and uses thereof
ES2195939T3 (es) Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.
AR047765A1 (es) Metodos y composiciones que comprenden ilex
JP2004091338A (ja) ウレアーゼ阻害剤、アンモニア臭抑制剤およびおむつかぶれ防止剤
WO2014144584A3 (en) Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
DK1638582T3 (da) Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
KR101284607B1 (ko) 천연물질을 함유한 저자극성 염모제
AR052840A1 (es) Composiciones para el cuidado oral que contienen flavonoides y flavanos
BRPI0416747A (pt) métodos e formulações para o tratamento de condições médicas relacionadas à dihidrotesterona elevada
CN108434174B (zh) 一种用于辅助龋齿治疗及预防龋齿的口腔喷剂及其制备方法
NO20090365L (no) Formuleringer omfattende et vitamin og anvendelse derav for fremstilling av beriket fode og formuleringer til personlig pleie
KR101794343B1 (ko) 석화 캘러스 배양물 제조방법, 석화 캘러스 배양물, 및 이를 포함하는 화장료 조성물

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee